Company / Revenue per Share
Korro Bio, Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.24
FY2025
5-year range
$0.00 / $1.09
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $0.24.
Based on SEC 10-K filings.
0.24 in FY2025 with a 5-year CAGR of -23.7%.
Declined from $0.41 to $0.24 over the past 3 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -15.9%
- 5-Year CAGR
- -23.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.24 | - |
| FY2024 | $0.00 | -100.0% |
| FY2022 | $0.41 | -62.7% |
| FY2021 | $1.09 | +16.0% |
| FY2020 | $0.94 | -91.9% |
| FY2019 | $11.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026